ResearcherThe University of Texas MD Anderson Cancer CenterNo recent work listed
Yu‐Qing Zhang
Matched on ORCID iD 0000-0001-7670-386X; OpenAlex author ID A5100401881. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 32
2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper
Papers 5
- ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the Gemcitabine Transporter ENT1 in Pancrea… First author DOI 10.1053/j.gastro.2019.10.038↗
- PIN1 Maintains Redox Balance via the c-Myc/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer Cells. Co-author DOI 10.1158/0008-5472.can-18-1968↗
- ZIP4 confers resistance to zinc deficiency-induced apoptosis in pancreatic cancer. First author DOI 10.4161/cc.28111↗
- A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth. Co-author DOI 10.1002/emmm.201302507↗
- Novel therapeutic modalities and drug delivery in pancreatic cancer - an ongoing search for improved efficacy. Co-author DOI 10.7573/dic.212244↗
Closest collaborators
The 25 strongest of 32 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jingxuan Yang · 4 shared papers, 2013–2020 · strength 0.25
- Paper ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the… DOI 10.1053/j.gastro.2019.10.038↗
- Paper PIN1 Maintains Redox Balance via the c-Myc/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pan… DOI 10.1158/0008-5472.can-18-1968↗
- Paper ZIP4 confers resistance to zinc deficiency-induced apoptosis in pancreatic cancer. DOI 10.4161/cc.28111↗
- Min Li · 3 shared papers, 2012–2020 · strength 0.22
- Paper ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the… DOI 10.1053/j.gastro.2019.10.038↗
- Paper PIN1 Maintains Redox Balance via the c-Myc/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pan… DOI 10.1158/0008-5472.can-18-1968↗
- Paper Novel therapeutic modalities and drug delivery in pancreatic cancer - an ongoing search for improved efficacy. DOI 10.7573/dic.212244↗
- Xiaobo Cui · 3 shared papers, 2013–2020 · strength 0.16
- Paper ZIP4 Increases Expression of Transcription Factor ZEB1 to Promote Integrin α3β1 Signaling and Inhibit Expression of the… DOI 10.1053/j.gastro.2019.10.038↗
- Paper ZIP4 confers resistance to zinc deficiency-induced apoptosis in pancreatic cancer. DOI 10.4161/cc.28111↗
- Paper A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth. DOI 10.1002/emmm.201302507↗
- Martín E. Fernández-Zapico · 2 shared papers, 2013–2020 · strength 0.12
- Xianjun Yu · 2 shared papers, 2013–2019 · strength 0.11
- Mingyang Liu · 1 shared paper, 2020 · strength 0.09
- Marc P. Stemmler · 1 shared paper, 2020 · strength 0.09
- Barish H. Edil · 1 shared paper, 2020 · strength 0.09
- Zhijun Zhou · 1 shared paper, 2020 · strength 0.09
- Thomas Brabletz · 1 shared paper, 2020 · strength 0.09
- Courtney W. Houchen · 1 shared paper, 2020 · strength 0.09
- Hanxiang Zhan · 1 shared paper, 2020 · strength 0.09
- Quanxing Ni · 1 shared paper, 2019 · strength 0.08
- Qingcai Meng · 1 shared paper, 2019 · strength 0.08
- Jie Hua · 1 shared paper, 2019 · strength 0.08
- Jin Xu · 1 shared paper, 2019 · strength 0.08
- Chen Liang · 1 shared paper, 2019 · strength 0.08
- Mingyang Liu · 1 shared paper, 2019 · strength 0.08
- Shunrong Ji · 1 shared paper, 2019 · strength 0.08
- Si Shi · 1 shared paper, 2019 · strength 0.08
- Yi Qin · 1 shared paper, 2019 · strength 0.08
- Min Li · 1 shared paper, 2014 · strength 0.05
- Sushovan Guha · 1 shared paper, 2014 · strength 0.05
- Qizhi Cathy Yao · 1 shared paper, 2013 · strength 0.03
- William E. Fisher · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.